XAIR
Beyond Air
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- Beyond Air received FDA Breakthrough Device Designation for LungFit GO to treat nontuberculous mycobacterial pulmonary diseaseAug 31, 2026
- NeuroNOS granted FDA orphan drug designation for glioblastoma, the most common and deadliest primary malignant brain cancer in adultsSep 8, 2025
- Beyond Air signs new international LungFit PH® distribution agreements, most notably in JapanAug 20, 2025